Targeting Rho kinase to restore endothelial barrier function following vascular scaffold implantation

Area of Science:

• Vascular biology and tissue engineering
• Endothelial cell biology and function
• Biomaterials and regenerative medicine

Background:

• Vascular scaffold implantation causes endothelial injury, compromising barrier integrity and promoting leukocyte/lipoprotein transmigration.
• Mechanical stretching of the vascular wall activates RhoA/Rho kinase, leading to actomyosin contractility and destabilized adherens junctions, resulting in endothelial barrier dysfunction.

Approach:

• Reviewing the role of Rho GTPases in endothelial barrier disruption post-scaffold implantation.
• Examining the mechanisms of endothelial barrier stabilization via RhoA downregulation and Rap1/Rac1 GTPase-mediated cytoskeletal reorganization.
• Highlighting therapeutic strategies targeting Rho-associated protein kinases to restore endothelial barrier function.

Key Points:

• Endothelial barrier dysfunction after scaffold implantation is mediated by RhoA signaling.
• Adherens junction stability and cytoskeletal organization are crucial for endothelial barrier integrity.
• Rap1 and Rac1 GTPases promote endothelial barrier stabilization by counteracting RhoA's disruptive effects.

Conclusions:

• Rho GTPases play a critical role in the disruption of endothelial barrier integrity following vascular scaffold implantation.
• Targeting downstream Rho-associated protein kinases offers a promising strategy to restore endothelial barrier integrity and stability.